%0 Journal Article
%A 
%T Optimizing Patient Selection for Bevacizumab Plus Irinotecan in Recurrent High Grade Glioma: Superiority of the Neutrophil-to-Lymphocyte Ratio Over Other Systemic Inflammation Indices
%D 2026
%F 
%P 37-45
%V 10
%N 1
%R doi:10.14744/ejmi.263037
%U https://dx.doi.org/10.14744/ejmi.263037